Ocugen Stock News

Ocugen Inc. shares OCGN, +12.51% climbed 9% early Friday after a federal appeals court on Thursday upheld a lower court's ruling against shareholders who alleged the biotech company misled investors a

Novavax and Ocugen were early contenders in the coronavirus vaccine race -- but didn't meet investors' expectations in that market. As a result, shares of both companies have plummeted.

MALVERN, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cel

MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel g

MALVERN, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel g

Ocugen (NASDAQ: OCGN ) stock fans will want to keep an eye on the clinical-stage biopharmaceutical company as it has big news coming on Wednesday. That's when Ocugen plans to hold a Clinical Showcase

MALVERN, Pa., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell

Ocugen (NASDAQ: OCGN ) stock is on the rise Tuesday after the clinical-stage biopharmaceutical company announced a new vaccine trial. According to a press release from the company, its vaccine for the

MALVERN, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell

MALVERN, Pa., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell

Here's a personal story – while millionaire-maker stocks to buy seems like a fantastical notion, it's not an impossible one. Roughly two-and-a-half years ago, I shared how I bought my house free and

MALVERN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell

Shares of Ocugen (NASDAQ: OCGN ) stock have been on the move today. Following a surge of more than 3% this morning, shares of OCGN stock have since settled down to an almost flat gain of 0.2%.

Novavax and Ocugen fell behind in the coronavirus vaccine race and their shares have plummeted. Now, both companies have revised their strategies.

Ocugen (NASDAQ: OCGN ) stock has trended steadily downward for the past six months, shedding almost 70% of its value. While things have looked bleak for some time, they took a turn for the worse yeste